ALB and non-small cell lung carcinoma: This Phase II trial is studying how well giving carboplatin and paclitaxel albumin-stabilized nanoparticle formulation together with radiation therapy and erlotinib works in treating patients with Stage III NSCLC that cannot be removed by surgery.